Wetzels JF - Search Results

1

Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.

Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ. Hofstra JM, et al. Among authors: wetzels jf. Clin J Am Soc Nephrol. 2011 Jun;6(6):1286-91. doi: 10.2215/CJN.07210810. Epub 2011 Apr 7. Clin J Am Soc Nephrol. 2011. PMID: 21474589 Free PMC article.

2

An overview of immunosuppressive therapy in idiopathic membranous nephropathy.

Maas R, Hofstra JM, Wetzels JF. Maas R, et al. Among authors: wetzels jf. Minerva Med. 2012 Aug;103(4):253-66. Minerva Med. 2012. PMID: 22805618 Review.

3

Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?

Hofstra JM, Wetzels JF. Hofstra JM, et al. Among authors: wetzels jf. Neth J Med. 2012 Apr;70(3):109-13. Neth J Med. 2012. PMID: 22516574 Free article. Review.

4

Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.

Hofstra JM, Deegens JK, Willems HL, Wetzels JF. Hofstra JM, et al. Among authors: wetzels jf. Nephrol Dial Transplant. 2008 Aug;23(8):2546-51. doi: 10.1093/ndt/gfn007. Epub 2008 Feb 28. Nephrol Dial Transplant. 2008. PMID: 18308774

5

Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.

Hofstra JM, Deegens JK, Steenbergen EJ, Wetzels JF. Hofstra JM, et al. Among authors: wetzels jf. Nephrol Dial Transplant. 2008 Oct;23(10):3160-5. doi: 10.1093/ndt/gfn190. Epub 2008 Apr 10. Nephrol Dial Transplant. 2008. PMID: 18403431

6

Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.

Hofstra JM, Wetzels JF. Hofstra JM, et al. Among authors: wetzels jf. Nephrol Dial Transplant. 2008 Nov;23(11):3534-8. doi: 10.1093/ndt/gfn350. Epub 2008 Jun 17. Nephrol Dial Transplant. 2008. PMID: 18559961

7

Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.

Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF. Hofstra JM, et al. Among authors: wetzels jf. Nephrol Dial Transplant. 2010 Jan;25(1):129-36. doi: 10.1093/ndt/gfp390. Epub 2009 Aug 8. Nephrol Dial Transplant. 2010. PMID: 19666912 Clinical Trial.

8

Alkylating agents in membranous nephropathy: efficacy proven beyond doubt.

Hofstra JM, Wetzels JF. Hofstra JM, et al. Among authors: wetzels jf. Nephrol Dial Transplant. 2010 Jun;25(6):1760-6. doi: 10.1093/ndt/gfq017. Epub 2010 Feb 3. Nephrol Dial Transplant. 2010. PMID: 20133280 Review. No abstract available.

9

Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy.

van den Brand JA, Hofstra JM, Wetzels JF. van den Brand JA, et al. Among authors: wetzels jf. Clin J Am Soc Nephrol. 2011 Dec;6(12):2846-53. doi: 10.2215/CJN.04020411. Clin J Am Soc Nephrol. 2011. PMID: 22157712 Free PMC article.

10

Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.

van den Brand JA, Hofstra JM, Wetzels JF. van den Brand JA, et al. Among authors: wetzels jf. Clin J Am Soc Nephrol. 2012 Aug;7(8):1242-8. doi: 10.2215/CJN.00670112. Epub 2012 May 17. Clin J Am Soc Nephrol. 2012. PMID: 22595828 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

580 results

Search Page

Filters